Womens Health Investment Outlook 2026

Forward signals Globally, women in LMICs account for approximately 90% of maternal deaths, with conditions such as hypertensive disorders, haemorrhage and infection remaining the leading preventable causes.81 In the US, the rate of 22 maternal deaths per 100,000 live births is more than twice the rate of peer nations.82 The rising prevalence of high-risk pregnancies – driven by hypertension, obesity, diabetes and advanced maternal age – is fuelling growing demand for remote maternal health monitoring.The American College of Obstetricians and Gynecologists (ACOG) now recommends remote patient monitoring in prenatal and postpartum care, signalling regulatory and clinical endorsement.83 Broader integration of maternal monitoring into telehealth and virtual care platforms, coupled with employer and payer-driven programmes, is accelerating adoption. Reasons for optimism –Urgent demand: High maternal morbidity and mortality create non-discretionary, policy- backed demand for scalable monitoring solutions that extend access to high-risk and rural populations. –Emerging exit pathways: Reimbursement validation and early public listings indicate credible routes to liquidity as the category matures. –Partnerships: Integration with hospital systems, payers and telehealth providers accelerates adoption and lowers go-to-market costs, improving capital efficiency. –Value creation: Remote maternal health monitoring improves both maternal and neonatal outcomes, reducing the strain on healthcare systems and generating measurable savings for payers and systems.84 Points of caution for investors –Evidence and reimbursement risk: Large- scale, randomized trials remain limited, and reimbursement structures vary widely across payers and states. –Digital access disparities: Adoption may be constrained in low-income or rural populations that lack the necessary technical infrastructure. Women’s Health Investment Outlook 25